Gilliland Jeter Wealth Management LLC 89bio, Inc. Transaction History
Gilliland Jeter Wealth Management LLC
- $287 Billion
- Q1 2024
A detailed history of Gilliland Jeter Wealth Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Gilliland Jeter Wealth Management LLC holds 32,926 shares of ETNB stock, worth $250,237. This represents 0.13% of its overall portfolio holdings.
Number of Shares
32,926
Previous 19,000
73.29%
Holding current value
$250,237
Previous $212 Million
80.59%
% of portfolio
0.13%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$95.8 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$56.1 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$50.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$47.9 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$42.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $353M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...